Elucidating epigenetic landscape of gastric premalignant lesions through genome-wide mapping of 5-hydroxymethylcytosines: A 12-yearmedian follow-up study

Abstract

	•A largest longitudinal follow-up study of gastric precursor lesions in Chinese patients.
	•Revealing novel 5hmC molecular landscape linked to gastric premalignant lesions.
	•The feasibility of an innovative 5hmC-based predictive model for assessing gastric cancer progression risk.

Keywords

5-hydroxymethylcytosine / cancer prevention / gastric adenocarcinoma / gastric premalignant lesions / machine learning

References

[1] SmythEC, Nilsson M, GrabschHI, et al. Gastric cancer. Lancet North Am Ed. 2020; 396: 635-648.

[2] YanX, LeiL, LiH, et al. Stomach cancer burden in China: epidemiology and prevention. Chin J Cancer Res. 2023; 35: 81.

[3] WeedenCE, HillW, LimEL, Grönroos E, SwantonC. Impact of risk factors on early cancer evolution. Cell. 2023; 186: 1541-1563.

[4] KoulisA, BuckleA, BoussioutasA. Premalignant lesions and gastric cancer: current understanding. World J Gastrointest Oncol. 2019; 11: 665-678.

[5] LeungWK, SungJJY. Intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther. 2002; 16: 1209-1216.

[6] BlairVR, McLeodM, CarneiroF, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol. 2020; 21: e386-e397.

[7] NieminenAA, KonttoJ, PuolakkainenP, et al. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis. World J Gastroenterol. 2020; 26: 3447-3457.

[8] MoosaviA, Ardekani AM. Role of epigenetics in biology and human diseases. Iran Biomed J. 2016; 20: 246-258. doi:10.22045/ibj.2016.01

[9] CorreaP. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-6740.

[10] WangF, MengW, WangB, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014; 345: 196-202.

[11] SpagnolLW, Polettini J, SilveiraDA, WegnerGRM, PaivaDFF. P16 gene promoter methylation is associated with oncogenesis and progression of gastric carcinomas: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2022; 180: 103843.

[12] HideuraE, Suehiro Y, NishikawaJ, et al. Blood free-circulating DNA testing of methylated RUNX3 is useful for diagnosing early gastric cancer. Cancers (Basel). 2020; 12: 789.

[13] XuJ, LiN, DengW, Luo S. Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer. Bioengineered. 2021; 12: 1286-1298.

[14] ChangM-S, UozakiH, ChongJ-M, et al. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res. 2006; 12: 2995-3002.

[15] AnC, ChoiI-S, YaoJC, et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res. 2005; 11: 656-663.

[16] LiY, LiangJ, HouP. Hypermethylation in gastric cancer. Clin Chim Acta. 2015; 448: 124-132.

[17] HermanJG. Hypermethylation of tumor suppressor genes in cancer. Semin Cancer Biol. 1999; 9: 359-367.

[18] RenY, ZhangZ, SheY, et al. A highly sensitive and specific non-invasive test through genome-wide 5-hydroxymethylation mapping for early detection of lung cancer. Small Methods. 2023; 8: 2300747.

[19] CuiX-L, NieJ, KuJ, et al. A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation. Nat Commun. 2020; 11: 6161.

[20] CaiJ, ZengC, HuaW, et al. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas. Neurooncol Adv. 2021; 3: vdab049.

[21] TabishAM, ArifM, SongT, et al. Association of intronic DNA methylation and hydroxymethylation alterations in the epigenetic etiology of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2019; 317: H168-H180.

[22] Rodríguez-AguileraJR, EcsediS, Goldsmith C, et al. Genome-wide 5-hydroxymethylcytosine (5hmC) emerges at early stage of in vitro differentiation of a putative hepatocyte progenitor. Sci Rep. 2020; 10: 7822.

[23] PfeiferGP, XiongW, HahnMA, Jin S-G. The role of 5-hydroxymethylcytosine in human cancer. Cell Tissue Res. 2014; 356: 631-641.

[24] LiW, ZhangX, LuX, et al. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res. 2017; 27: 1243-1257.

[25] CaiJ, ChenL, ZhangZ, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. 2019; 68: 2195-2205.

[26] ZengC, StroupEK, ZhangZ, et al. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Commun (Lond). 2019; 39: 12.

[27] WuF, LiX, LoosoM, et al. Spurious transcription causing innate immune responses is prevented by 5-hydroxymethylcytosine. Nat Genet. 2023; 55: 100-111.

[28] CuiX-L, NieJ, KuJ, et al. A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation. Nat Commun. 2020; 11: 6161.

[29] DixonMF, GentaRM, YardleyJH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996; 20: 1161-1181.

[30] Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14: 101-112.

[31] BosmanFT, Carneiro F, HrubanRH, TheiseND. WHO Classification of Tumours of the Digestive System. IARC Publications.

[32] HanD, LuX, ShihAH, et al. A highly sensitive and robust method for genome-wide 5hmC profiling of rare cell populations. Mol Cell. 2016; 63: 711-719.

[33] SongC-X, Szulwach KE, FuY, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol. 2011; 29: 68-72.

[34] LangmeadB, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9: 357-359.

[35] LoveMI, HuberW, AndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15: 550.

[36] JohnsonWE, LiC, RabinovicA. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007; 8: 118-127.

[37] BenjaminiY, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995; 57: 289-300.

[38] EbrahimpoorM, GoemanJJ. Inflated false discovery rate due to volcano plots: problem and solutions. Brief Bioinform. 2021; 22: bbab053.

[39] HarrisMA, ClarkJ, IrelandA, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004; 32: D258-D261.

[40] KanehisaM, SatoY, KawashimaM, et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016; 44: D457-D462.

[41] HuangDW, Sherman BT, LempickiRA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37: 1-13.

[42] WuT, HuE, XuS, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.

[43] GentlemanRC, CareyVJ, BatesDM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004; 5: R80.

[44] WangQ, QiaoW, ZhangH, et al. Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma. Front Immunol. 2022; 13: 1019638.

[45] UdaltsovaN, Silverberg MJ. SAS® macros for standard incidence ratio calculation. https://www.lexjansen.com/wuss/2014/33_Final_Paper_PDF.pdf

[46] ZhangY, SunL, LeiC, et al. A sweet warning: mucin-type O-glycans in cancer. Cells. 2022; 11: 3666.

[47] ZhangY-L, WangR-C, ChengK, et al. Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med. 2017; 14: 90-99.

[48] OhshimaH, SawaT, AkaikeT. 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal. 2006; 8: 1033-1045.

[49] PeiJ, VeluP, ZareianM, et al. Effects of syringic acid on apoptosis, inflammation, and AKT/mTOR signaling pathway in gastric cancer cells. Front Nutr. 2021; 8: 788929.

[50] AjeigbeK, Aibangbee K, SaeedS, et al. Folic acid protects and heals gastric mucosa: role of acid output, inflammatory cytokines, angiogenic and growth factors. J Basic Appl Zool. 2022; 83: 15.

[51] KoushyarS, PowellAG, VincanE, Phesse TJ. Targeting Wnt signaling for the treatment of gastric cancer. Int J Mol Sci. 2020; 21: 3927.

[52] TodiscoA. Regulation of gastric metaplasia, dysplasia, and neoplasia by bone morphogenetic protein signaling. Cell Mol Gastroenterol Hepatol. 2017; 3: 339-347.

[53] StrehlJD, HoegelJ, HornicekI, et al. Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa. Int J Clin Exp Pathol. 2014; 7: 2091-2101.

[54] GarusiE, RossiS, PerrisR. Antithetic roles of proteoglycans in cancer. Cell Mol Life Sci. 2012; 69: 553-579.

[55] CorreaP, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012; 13: 2-9.

[56] LiD, Bautista MC, JiangS-F, et al. Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: a population-based study. Am J Gastroenterol. 2016; 111: 1104-1113.

[57] VannellaL, LahnerE, OsbornJ, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010; 31: 1042-1050.

[58] CaiQ, ZhuC, YuanY, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019; 68: 1576-1587.

[59] ZhangW, LiZ, AkramMS, et al. Gastric cancer screening methods: a comparative study of two scoring methods. Cancer Manag Res. 2021; 13: 5785-5791.

[60] XiaoZ, WuW, WuC, et al. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma. Mol Oncol. 2021; 15: 138-150.

[61] TianX, SunB, ChenC, et al. Circulating tumor DNA 5-hydroxymethylcytosine as a novel diagnostic biomarker for esophageal cancer. Cell Res. 2018; 28: 597-600.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary ^{中 Eng} ×

Note: Please be aware that the following content is generated by artificial intelligence. This website is not responsible for any consequences arising from the use of this content.

AI Summary AI Mindmap

×

Share on WeChat

Part of a collection:

86

Accesses

0

Citation

Altmetric

Detail

Sections

Recommended

[62] GulerGD, NingY, KuC-J, et al. Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. Nat Commun. 2020; 11: 5270.